Respiratory physicians in NSW are seeking research collaborators to take part in a head to head trial of mepolizumab and omalizumab in patients with severe allergic and eosinophilic asthma. Professor Peter Wark, a senior respiratory specialist at John Hunter Hospital and the University of Newcastle, is hoping to recruit 160 patient across Australia and New ...
Trial will inform choice between mAbs in severe asthma
By Michael Woodhead
12 Feb 2019